EU Legal Action Over Vaccines "Without Merit": AstraZeneca

"We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible," the company said.

EU legal action taken against AstraZeneca over shortfalls in its delivery of Covid vaccines is "without merit", the drugs giant said Monday. "We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible," the company said in a statement after the European Commission launched proceedings. AstraZeneca said it had "fully complied with the Advance Purchase Agreement with the European Commission". It added that in line with AstraZeneca's forecast, the company is set to deliver almost 50 million doses to European nations by the end of April.